Sugi Predict

Sugi Predict / Compounds / Dodecane

Dodecane

Dodecane

SCHEMBL5903124

CCCCCCCCCCCC.O=S(=O)([O-])[O-].[Na+].[Na+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Dodecane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 2/20 0.61
▸ TSHR P16473 2/20 0.61
▸ GLA P06280 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ EPHX2 P34913 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ THRB P10828 1/20 0.53
▸ FAAH O00519 2/20 0.50
▸ CES2 O00748 3/20 0.48
▸ CES1 P23141 3/20 0.48
▸ CA2 P00918 7/20 0.44
▸ CA1 P00915 6/20 0.44
▸ CA9 Q16790 6/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA3 P07451 2/20 0.44
▸ CA4 P22748 2/20 0.44
▸ CA6 P23280 2/20 0.44
▸ CA5A P35218 2/20 0.44
▸ CA7 P43166 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexadecane SCHEMBL27472157 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Sulfuric Acid SCHEMBL29027387 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Decane SCHEMBL3962532 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Tetradecane SCHEMBL2679723 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Octane SCHEMBL7174098 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Pentadecane SCHEMBL13370387 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Heptane SCHEMBL25268199 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Sulfuric Acid SCHEMBL29238029 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Tetradecane SCHEMBL3394343 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1
Sulfuric Acid SCHEMBL27540382 1.00 RECQL (0.61) RECQLTSHRGLAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105482914-A Multifunctional woolen sweater detergent and preparation method therefor JIANG YONG 2016-04-13 — — CN claimed
CN-117209483-A Benzofuran derivative and preparation method and application thereof 扬州中宝药业股份有限公司 2023-12-12 — — CN disclosed
WO-2023197984-A1 FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF FUSED RING COMPOUND 成都海博为药业有限公司 2023-10-19 — — WO disclosed
WO-2023198055-A1 POLYMORPH OF 7,8-DIHYDROXYFLAVONE, AND PREPARATION METHOD THEREFOR 泉州海创医药科技有限公司 2023-10-19 — — WO disclosed
WO-2023115806-A1 MODIFIED POLYMER FILM AND PREPARATION METHOD THEREFOR, AND METALLIZED POLYMER FILM AND USE 江阴纳力新材料科技有限公司 2023-06-29 — — WO disclosed
WO-2023005022-A1 GYPSUM BOARD AND PREPARATION METHOD THEREFOR 北新集团建材股份有限公司 2023-02-02 — — WO disclosed
WO-2022242768-A1 USE OF PYRROLOPYRIMIDINE COMPOUND 广州嘉越医药科技有限公司 2022-11-24 — — WO disclosed
WO-2022134837-A1 PYRROLE DERIVATIVE, AND PREPARATION METHOD AND USE THEREFOR 深圳市祥根生物医药有限公司 2022-06-30 — — WO disclosed
WO-2022121517-A1 BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USE THEREOF 成都海博为药业有限公司 2022-06-16 — — WO disclosed
WO-2022116451-A1 CASSAVA FIELD POST-EMERGENCE HERBICIDE TAKING EFFICIENT HALOXYFOP-METHYL AS EFFECTIVE COMPONENT 海南大学 2022-06-09 — — WO disclosed
CN-104749881-A Hybrid carbon black, and coating composition and light-shielding material comprising the same IND TECH RES INST 2015-07-01 — — CN disclosed
CN-104602675-A Nanoparticles of indirubin, derivatives thereof, and methods of making and using the same PHOSPHOREX INC 2015-05-06 — — CN disclosed
CN-102321077-A Chromane substituted benzimidazoles and their use as acid pump inhibitors RAQUALIA PHARMA INC 2012-01-18 — — CN disclosed
CN-101341149-B Chromane-substituted benzimidazoles and their use as acid pump inhibitors RAQUALIA PHARMA INC 2011-06-08 — — CN disclosed
CN-101341149-A Chromane-substituted benzimidazoles and their use as acid pump inhibitors PFIZER (US) 2009-01-07 — — CN disclosed
US-20060111242-A1 Powder formulations BAYER CROPSCIENCE AG (DE) 2006-05-25 — — US disclosed
EP-1515604-A1 POWDER FORMULATIONS Bayer CropScience Aktiengesellschaft (DE) 2005-03-23 — — EP disclosed
WO-2003105584-A1 POWDER FORMULATIONS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-12-24 — — WO disclosed
US-5593811-A Multilayer, sheet-like, photosensitive recording material for the production of printing plates BASF LACKE+FARBEN AKTIENGESELLSCHAFT (DE) 1997-01-14 — — US disclosed
US-5213934-A Core of colorant and binder grafted to polymeric shell XEROX CORPORATION (US) 1993-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111242-A1 Powder formulations PNN, AGPS, SAMM50 RECQL 1376/4885TSHR 4723/4885GLA 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.